Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase Ib/II clinical trial (SYS 6090 -008) of the SYS 6090 injection combination treatment plan developed by the group for the treatment of colorectal cancer has been officially launched at the first research center in China.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase Ib/II clinical trial (SYS 6090 -008) of the SYS 6090 injection combination treatment plan developed by the group for the treatment of colorectal cancer has been officially launched at the first research center in China.